3,098 press releases indexed under healthcare.
(PR-inside.com) NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, ON / ACCESS Newswire / July 15, 2026 / Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB:RVVTF)(CSE:RVV)(FRANKFURT:31R), a life sciences company focused on infectious diseases and medical countermeasures, announces that it has closed the first tranche of its previously announced non-brokered private placement for gross proceeds of $246,920 (the "Private Placement"). The Private Placement consisted of the issuance and sale of 7,716,250 units of the Company ("Units"), at a price of $0.032 per Unit. Each Unit issued pursuant to the Private Placement consists of one common share of ..
SAN JOSE, Calif. , July 15, 2026 /PRNewswire/ -- Maiden Lane Medical, a leading patient-centered multi-specialty healthcare organization, has announced a strategic partnership with Flexzo Ai to modernize clinician recruitment, accelerate speciality services expansion, and support...
In the news release, BOND Trial Aims to Improve Support for Families Facing Congenital Heart Disease, issued 14-Jul-2026 by Cincinnati Children's Hospital Medical Center over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows,...
MONROE, La., July 15, 2026 /PRNewswire/ -- Northeast Delta Human Services Authority (NEDHSA) has entered into a new partnership with Louisiana Love Home for Children to expand access to behavioral health services, prevention programming, and integrated care for girls residing at the...
MURFREESBORO, Tenn., July 15, 2026 /PRNewswire/ -- National Health Investors, Inc. (NYSE: NHI) announced details for the release of its results for the second quarter ended June 30, 2026. NHI plans to issue its earnings release after the market closes on Monday, August 10, 2026, and will...
MELBOURNE, Australia and INDIANAPOLIS, July 16, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) and St Vincent’s Hospital today announced that the first patients have been dosed with TLX597-Tx ( 177 Lu-DOTA-HYNIC-panPSMA) in the OPTIMAL-e trial, led by Professor Louise Emmett for patients with metastatic hormone-sensitive prostate cancer (mHSPC) at St Vincent’s Hospital in Sydney, Australia.
NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2026 financial results on Wednesday, August 5, 2026 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 a.m. Eastern Time that day.
ALISO VIEJO, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced a planned leadership transition effective July 20, 2026, with Aziz Mottiwala appointed President and Chief Executive Officer, succeeding Ron Kurtz, M.D., who will continue to serve as Chief Medical Officer.
(PR-inside.com) UPPSALA, SE / ACCESS Newswire / July 15, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB announced today that it has entered into a long-term agreement with Philips Electronics Nederland, B.V. through Philips Hospital Patient Monitoring business, a global leader in patient monitoring systems. The collaboration will explore and develop potential future solutions leveraging the companies' respective proprietary technologies. These solutions are expected to address market segments that complement Senzime's existing product portfolio and sales channels. The resulting solutions will be commercialized through Philips' global organization. Within Senzime, these solutions will be managed alongside the company's existing product portfolio and sales ..